Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Omeros Corp (NASDAQ:OMER)

10.10
Delayed Data
As of 4:00pm ET
 +0.05 / +0.50%
Today’s Change
7.20
Today|||52-Week Range
16.80
-35.79%
Year-to-Date
Why Omeros Corporation Stock Popped 47.9% in November
Dec 05 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close10.05
Today’s open10.12
Day’s range9.89 - 10.56
Volume683,547
Average volume (3 months)632,445
Market cap$431.3M
Dividend yield--
Data as of 4:00pm ET, 12/09/2016

Growth & Valuation

Earnings growth (last year)+9.91%
Earnings growth (this year)+16.43%
Earnings growth (next 5 years)+85.00%
Revenue growth (last year)+2,406.31%
P/E ratioNM
Price/Sales43.74
Price/Book--

Competitors

----
PTCTPTC Therapeutics Inc-0.07-0.54%
FLMLFlamel Technologies ...-0.02-0.19%
CTMXCytomX Therapeutics ...+0.07+0.57%
Data as of 4:00pm ET, 12/09/2016

Financials

Next reporting dateMarch 20, 2017
EPS forecast (this quarter)-$0.46
Annual revenue (last year)$13.5M
Annual profit (last year)-$75.1M
Net profit margin-555.90%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Gregory A. Demopulos
CFO, Treasurer, Chief Accounting Officer &
VP
Michael A. Jacobsen
Corporate headquarters
Seattle, Washington

Forecasts


Search for Jobs